Hims & Hers enters Canadian market with a digital weight loss program leveraging generic semaglutide, signaling increased competition and accessibility in the growing GLP-1 and obesity treatment sector.

Hims & Hers Health expands into Europe with its acquisition of ZAVA, extending its digital healthcare services to the UK, Germany, France, and Ireland. Learn about the deal and what it means for personalized health access.